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Minutes of the Meeting 
The Department of Health and Human Services (HHS) and the Centers for Disease 
Control and Prevention (CDC) convened a meeting of the Advisory Committee on 
Childhood Lead Poisoning Prevention (ACCLPP). The proceedings were held on 
March 21-22, 2006 atthe Magnolia Hotel in Houston, Texas. 
Opening Sea.lon 
Dr. Carla Campbell, the ACCLPP Chair, called the meeting to order at 8:40 a.m. on 
March 21, 2006. She welcomed the attendees to the proceedings and opened the floor 
for introductions. The list of participants is appended to the minutes as Attachment 1 . 
Mr. Stephen Williams, Director of the Houston Health and Human Services Department, 
welcomed ACCLPP to Houston. He announced that Houston is now placing more 
emphasis on children's health overall; the impact of behavioral health issues on 
children; and the integration of the Women, Infants and Children, Healthy Homes, 
Maternal and Child Health, and Childhood Lead Poisoning Prevention Programs 
(CLPPP). Research and data collection components will be incorporated into all of 
these programs to more closely focus on the epidemiology and health effects of lead 
and other issues. 
ACCLPP applauded the city of Houston in recognition of its extraordinary outreach 
efforts during Hurricane Katrina. 
In the temporary absence of Dr. Mary Jean Brown, the ACCLPP Executive Secretary 
and Lead POisoning Prevention Branch (LPPB) Chief, Dr. Campbell announced that 
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members with a conflict of interest are responsible for identifying these issues and 
recusing themselves from voting or participating in these discussions. 
!;i~ql]llPr.>w_...-~- II'. ~1.l.·IIIr' 
Update on the ACCLPP Clinical Paper 
Dr. Helen Binns is the ACCLPP liaison to the American Academy of Pediatrics (AAP) 
and served as the primary author of ACCLPP's paper on Understanding Blood Lead 
Levels and Primary Prevention. She reported that the final draft of the paper was 
resubmitted to Pediatrics on March 8, 2006 to reflect comments by Pediatrics reviewers, 
ACCLPP members and liaisons. 
The comments resulted in an extensive revision and expansion of the document, but Dr. 
Binns was pleased to announce that Pediatrics accepted the clinical paper for 
publication. She also reported that the paper was submitted to the Morbidity and 
Mortality Weekly Report (MMWR) and may be placed on the September 2006 
publication calendar. 
ACCLPP applauded Dr. Binns on her outstanding leadership over the past three years 
in developing and repeatedly revising the clinical paper to reflect ACCLPP's comments 
and diverse perspectives. The members noted that Dr. Binns' efforts are the primary 
reason ACCLPP produced a high-quality document. 
........-w_"IIII__ 

Improving Model HQuslng Codes (MHCs) for Primary Prevention 
Ms. Jane Malone is the ACCLPP liaison to the Alliance for Healthy Homes (AFHH). 
She described existing gaps in and ongoing efforts to improve MHCs for primary 
prevention. States and localities traditionally wrote property maintenance and 
construction codes based upon model codes developed by Building Officials and Code 
Administrators International, the International Conference of Building Officials, and 
Southern Building Code Congress International. 
In 1994, the three organizations jointly established the International Code Council (ICC) 
to serve as the major source for codes on maintaining, building and repairing real 
estate. The ICC was also formed to foster uniform adoption of a single set of codes, 
facilitate consistent code enforcement and improve the quality of construction. At this 
time, -30 states adopt ICC codes. Any interested individual or group may submit a 
code change proposal to ICC and participate in the deliberations. Important deadlines 
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in the 2006-2007 ICC code development schedule are March 24, 2006 to submit current 
code change proposals and September 20-30, 2006 to attend code development 
hearings. 
At this time, only four model codes contribute to the prevention of lead poisoning. First, 
the international property maintenance code governs standards for occupancy of units 
and states that "peeling, chipping, flaking or abraded paint shall be repaired, removed or 
covered." However, this code only addresses lead safety in a footnote as an option 
instead of providing specific standards to protect children. Many communities view the 
language as a "cosmetic" issue that is less important than other housing hazards. 
Second, international residential and building codes govern construction, but are 
unclear. Most notably, some renovations in the United States are not subject to codes, 
permits or standards. Third, the international existing building code was recently 
incorporated into ICC codes to address rehabilitation construction when buildings are 
repaired. However, the code does not mention lead or paint. 
Fourth, the hazard abatement for existing building (HAEB) code focuses on correcting 
hazards in the course of renovation. The HAEB committee drafted a code specifically to 
address hazards in existing buildings. The public can review and submit comments on 
the draft code through April 15, 2006 on the ICC web site. Overall, none of the model 
construction codes cover lead-safe work practices (LSWPs) or renovation. 
Other rehabilitation construction codes have been developed by the state of New 
Jersey, National Fire Protection Association and the U.S. Department of Housing and 
Urban Development (HUD). The U.S. Environmental Protection Agency (EPA) has a 
pending renovation and remodeling rule. Similar to the model codes, none of these 
codes include specific language to protect the health of children, prohibit dangerous 
work practices, or address LSWPs related to painted surfaces, lead hazards or cleanup. 
The exclusion of this language is primarily due to building officials rather than health 
departments having authority for housing codes. 
Several actions have been taken at state and local levels to achieve primary prevention 
through code enforcement activities. The state of New Jersey passed a multi-family 
housing law and a regulation that requires dust clearance testing after rehabilitation 
construction. A bill in California specifically addresses lead hazards. New York City 
and other jurisdictions prohibit lead hazards in rental housing. Some states require 
LSWP training and several local regulations focus on housing occupied by children <6 
years of age. Ten states now prohibit uncontrolled sanding and other dangerous work 
practices during remodeling and renovation. 
ACCLPP Meeting Minutes 
Page 3 March 21-22, 2006 
AFHH published lead-safe housing policy guidance to assist jurisdictions in developing 
policies for pre-1970 rental properties, high-risk units and extreme situations. Over the 
next year, AFHH and its partners will place more emphasis on the decision-making 
process by code enforcement agencies and accountability for housing health hazards to 
children beyond health departments. 
Ms. Malone proposed several options for ACCLPP to consider in filling existing gaps 
and improving MHCs for primary prevention. 
• 	 A national initiative should be launched with two overarching goals. First, 
MHCs should be developed with specific language that requires peeling 
paint to be absent in rental housing and LSWPs to be used when 
removing peeling paint in older housing. Second, explicit language should 
be incorporated into construction codes requiring appropriate cleanup of 
painted surfaces and removal of dust hazards. 
• 	 ACCLPP could be extensively involved in the national initiative by 
expanding the public health legacy related to housing conditions; 
engaging code enforcement agencies and other groups with responsibility 
for developing and approving MHCs; and using these collaborations to 
advance primary prevention beyond state and local health departments. 
• 	 ACCLPP could develop a position statement on the need to include lead 
safety language in MHCs and also provide comments on the draft HAEB 
code for hazards in existing buildings. 
• 	 ACCLPP could support national advocacy efforts to advance primary 
prevention with MHCs. Public health is often not represented during the 
decision-making process of developing and changing building codes to 
voice concerns about childhood lead poisoning and primary prevention. 
Three opportunities are available to address this issue. First, public health 
proponents can submit comments on HAEB's draft code for abating 
hazards in existing buildings. Second, public health can provide ongoing 
guidance to ICC about lead hazards when policies are developed that 
focus on housing-related hazards. Third, public health can make strong 
efforts to incorporate EPA's pending renovation and remodeling rule into 
MHCs if the language is established as policy in the future. 
Ms. Malone reiterated the critical need for ACCLPP's involvement in and support of 
efforts to advance primary prevention with MHCs. As CDC's advisory committee and 
outside expert on lead, she believed ACCLPP should take responsibility for 
communicating with model code entities and emphasizing the importance of including 
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specific health protection language in MHCs. Her position was that the documents and 
recommendations ACCLPP has generated to date are generic with unclear messages 
on this issue. 
Ms. Malone further noted that ACCLPP has not produced and disseminated a position 
statement on specific actions local model code entities should take in developing lead­
safe MHCs. She conveyed that ACCLPP's guidance on responding to and addressing 
the needs of lead-poisoned children has only been directed to health departments and 
the medical community. Ms. Malone emphasized that ACCLPP's solid expertise in lead 
will playa significant role in achieving primary prevention with MHCs and supporting 
ongoing efforts by AFHH and other groups. 
ACCLPP extensively discussed its potential role in leading or supporting new and 
ongoing initiatives to advance primary prevention with MHCs. The voting members and 
liaisons proposed the following options as ACCLPP's next steps in this effort. 
• 	 Establish a new ACCLPP writing group with the following charge. 
Develop ACCLPP's statement on the importance of lead and its housing­
based position on lead. Extract relevant portions from ACCLPP's primary 
prevention document and compile the text into a letter with succinct bullet 
points and an appendix. Disseminate ACCLPP's position statement to 
ICC, the HAEB committee and other code enforcement agencies. 
• 	 Establish workgroup 1 with ACCLPP members and liaisons who have 
experience in MHCs. Charge the new workgroup with developing 
language that supports states and local agencies in using MHCs to 
advance primary prevention. 
• 	 Establish workgroup 2 with ACCLPP members and ex officio 
representatives for EPA and HUD. Charge the new workgroup with 
conducting the following activities. Educate other ACCLPP members on 
definitions and the specific use of terminology in MHCs. Monitor new 
developments in MHCs and track the ICC code development process. 
Provide ACCLPP with regular updates on these activities over time. 
Respond to and support public comments on ICC codes submitted by 
AFHH and other groups. 
• 	 Ask the ACCLPP Chair to contact the ICC committee chair and members 
by telephone to further emphasize the need to incorporate lead-safe 
language into MHCs. Mention that ACCLPP's lead expertise will be 
available to ICC in this effort. 
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• 	 Explore the possibility of AFHH drafting ACCLPP's position statement due 
to its experience with and knowledge of MHCs. Circulate AFHH's draft to 
ACCLPP for review, comment and approval prior to dissemination. 
• 	 Submit an ACCLPP comment on the draft HAEB code to change "lead 
that is present in dangerous amounts." Inform the HAEB committee that 
this language is unrealistic and the text should be revised to focus on the 
"condition" rather than the "presence" of lead. 
• 	 Attempt to gather evidence or research to demonstrate the role of MHCs 
in changing practice or improving the standard of care. 
• 	 Urge ACCLPP to formally support new initiatives. For example, a national 
registry could be developed and published with previous and current 
addresses of children identified with elevated blood lead levels (EBLLs). 
A policy could be established in which local authorities are given one year 
to respond to the public registry with a plan to remediate the properties. 
Local models could be reviewed in this effort. Most notably, the city of 
Cleveland has identified -600 properties as sources of lead exposure to 
children, compiled these addresses into one list, and provided the city 
council with the list. 
• 	 Be mindful of the extensive amount of time and effort involved with the 
code development and revision process if ACCLPP agrees to become 
involved with MHCs. For example, stakeholders typically express diverse 
views about potential changes in costs due to a revised standard or code. 
Several years may be needed for stakeholders to reach agreement. 
• 	 Determine whether ACCLPP will be more effective in providing clear 
guidance on overcoming barriers to implementing lead-safe MHCs, 
particularly economic or educational challenges. Use ACCLPP as a 
mechanism to engage local advocates in the lay community to assist in 
the implementation of lead-safe MHCs. 
• 	 Distribute basic information on lead-safe MHCs to educate providers and 
increase endorsement, support and advocacy in the medical community. 
• 	 Encourage ACCLPP to formally support a policy in which existing LSWP 
guidance developed by EPA and HUD are uniformly accepted, adopted 
and incorporated into MHCs. structure the policy to specifically address 
LSWPs when a painted surface is disturbed, peeling paint as a potential 
lead hazard in older housing, lead hazard abatement, and LSWP 
certification and training of workers. 
Dr. Campbell was extremely pleased that the discussion resulted in ACCLPP's interest 
and willingness to address lead-safe MHCs. She agreed with Ms. Malone that 
ACCLPP's expertise and involvement in this initiative will play a significant role in the 
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prevention of lead exposures to children. She urged each member and liaison to submit 
individual comments on the draft HAEB code by April 15, 2006 because ACCLPP does 
not have sufficient time to develop a formal position statement by this deadline. 
Based on the discussion and general agreement among the voting members, Dr. 
Campbell summarized ACCLPP's next steps in improving MHCs for primary prevention. 
A writing group will be formed to draft a letter to ICC with the following key points. 
ACCLPP's concerns about lead safety and other housing issues that impact children's 
health will be emphasized. Citations and references for existing recommendations, 
suggested practices and regulations will be included. 
ICC will be encouraged to contribute to the safety of children by following existing 
guidance and including this language when developing or revising model codes. The 
writing group will complete the letter in time for ICC's code development hearings in 
September 2006. All drafts of the letter will be distributed to ACCLPP for review and 
comment. ACCLPP will revisit the writing group in the future to determine whether its 
scope should be broadened to monitor new developments in the MHC arena. 
Dr. Campbell confirmed that further discussions will be held to more clearly define the 
charge of the MHC writing group. Ms. Malone will serve as the chair; Ms. Angeloni, Dr. 
Binns, Ms. Johnson, Ms. Kite, Ms. Odie, Dr. Wynn-Stubbs and ACCLPP's ex officio 
representatives for EPA and HUD will serve as members. 
Update on ACCLPP'. Communications with HHS 
Dr. Campbell reported that ACCLPP has made numerous attempts over a long period of 
time to engage HHS in primary prevention through written communications, telephone 
conversations, and invitations to attend and present at ACCLPP meetings. To date, 
HHS has not responded to ACCLPP's requests. 
To advance this effort, Dr. Campbell drafted a ietter to the HHS Secretary emphas~zing 
the critical need for HHS to institutionalize primary prevention in all activities throughout 
the department. The letter provides an example to achieve this goal, such as reviewing 
the use of federal funding for the Temporary Assistance to Needy Families (TANF) 
Program. The letter also suggests that HHS review and identify the quality of housing 
to TANF recipients and determine whether funding is being directed toward lead-safe 
housing. The draft letter was circulated to ACCLPP for review and comment. Dr. 
Campbell solicited ACCLPP's input on the need to send the letter to the HHS Secretary 
and the contents of the document. 
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ACCLPP's suggestions on next steps in communicating with the HHS Secretary on 
primary prevention are outlined below. 
• 	 Continue to communicate with the HHS Secretary, but shift the focus from 
"primary prevention" to "child care" because TANF and the Administration 
for Children and Families Child Care Bureau will be merged in the HHS 
reorganization. 
• 	 Describe non-TANF examples of "institutionalizing primary prevention" 
throughout HHS, such as safety in child care or Head Start settings. 
• 	 Remind the HHS Secretary of the federal rule that requires the use of 
LSWPs and the removal of lead hazards in any activities supported by 
federal housing dollars. 
• 	 Replace the "EPA Administrator" with the correct title and address for the 
"HHS Secretary." 
• 	 Revise the first paragraph to succinctly and explicitly state ACCLPP's 
requests to the HHS Secretary. For example, "ACCLPP requests an HHS 
representative to attend the October 2006 meeting to discuss specific 
primary prevention issues." 
• 	 Minimize HHS's discomfort with potential disruptions in the chain of 
command by asking HUD to cosign ACCLPP's letter or collaborate in the 
process. 
• 	 Ask CDC to contact HHS to identify reasons for the lack of communication 
and difficulty in HHS representatives attending and presenting at meetings 
of an advisory committee to the HHS Secretary. 
Dr. Brown announced that she had less success at the CDC level than Dr. Campbell in 
encouraging an HHS representative to attend an ACCLPP meeting and discuss primary 
prevention issues. However, she contacted an HHS staff member who is extremely 
supportive of Medicaid and primary prevention issues. ACCLPP's draft letter will 
provide Dr. Brown with a solid tool to facilitate further discussions because HHS is 
embarrassed about the length of time that has passed for the Centers for Medicare and 
Medicaid Services (CMS) to respond to ACCLPP. 
Based on the discussion, Dr. Campbell summarized ACCLPP's next steps in this 
process. She will revise the draft letter in response to comments made during the 
meeting, but ACCLPP should feel free to submit additional changes in writing. She will 
circulate the revised letter to ACCLPP for review and comment. Dr. Campbell will 
finalize and send the letter to the HHS Secretary so long as ACCLPP does not submit 
major changes that require a formal vote bye-mail. Dr. Brown offered to convene a 
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conference call with a subgroup of ACCLPP members and LPPB staff with expertise in 
TANF issues to facilitate finalizing and sending the letter to the HHS Secretary. 
Update on LPPB Actlvltl•• 
Dr. Brown covered the following areas in her report. One, LPPB received a report of the 
death of a child due to lead poisoning that occurred in February 2006 in Minneapolis. 
The child was 4% years of age and had a BLL of 180 1J9/dL after swallowing a charm 
from a bracelet. The child presented with symptoms that were consistent with acute 
ingestion, nausea and vomiting over a two-week period, agitation and seizures. The 
child went into respiratory arrest and was declared brain dead before a BLL was 
available. 
No obvious lead hazards were found in the child's home, but the actual source is still 
pending investigation. The child's sibling is two years of age with a BLL <10 g/dL. By 
March 24, 2006, the U.S. Consumer Product Safety Commission (CPSC) will issue a 
consumer recall on the product and LPPB will publish a dispatch on the case in the 
MMWR to notify all CLPPPs and other partners. 
The MMWR article will strongly emphasize three key messages. Lead poisoning 
continues to be a part of the differential diagnosis for children with symptoms of 
increased inter-cranial pressure. Proactive steps are critically needed to prevent further 
deaths among children due to lead poisoning. Every effort must be made to discourage 
young children from placing foreign objects in their mouths. 
Two, LPPB published an MMWR article on March 3, 2006 to report three deaths 
associated with hypocalcemia from chelation therapy in Oregon, Pennsylvania and 
Texas. Both children were given disodium EDTA rather than calcium disodium EDTA. 
The adult case remains under investigation. LPPB made three key recommendations in 
the MMWR article. Healthcare providers who are unfamiliar with chelation therapy 
should consult with an expert. Hospitals should determine whether continued stocking 
of disodium EDT A is warranted due to the danger of this drug and the availability of less 
toxic alternatives. Healthcare providers and pharmacists should ensure that children do 
not receive disodium EDT A. 
The Food and Drug Administration (FDA) is conducting a safety evaluation of disodium 
EDTA and may issue language that is stronger than LPPB's recommendations. LPPB 
and the AAP Environmental Health Committee are attempting to jointly publish a paper 
in Pediatrics Experience and Reason on the use of disodium EDTA during chelation 
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therapy. MP has received numerous telephone calls from medical toxicologists about 
this issue, but none from pediatricians. The cases were covered by 66 newspapers. 
Three, LPPB finalized two toolkits to educate special populations. The easy-to-use and 
self-explanatory materials can be distributed to health, social service and other workers 
who serve high-risk populations. One train-the-trainer toolkit is targeted to state refugee 
health coordinators, refugee workers and resettlement agencies that serve newly 
arrived refugee children. The Office of Refugee Health and other federal agencies are 
extremely supportive of this initiative and will closely collaborate with LPPB to ensure 
the toolkit is widely distributed. Rhode Island has agreed to pilot the toolkit for refugee 
children. 
LPPB's CLPPP Community Awareness Pilot (CAP) project will be piloted to African 
American churches to involve grassroots organizations and community residents in lead 
poisoning prevention. During the pilot, LPPB will evaluate whether the toolkit was 
useful, helpful and easy to use and will make revisions based on feedback. Georgia 
has agreed to pilot the toolkit for the CLPPP CAP project. LPPB will widely disseminate 
both toolkits to state and local partners. 
Four, LPPB gathered data on the top 25 communities that reported children with EBLLs 
from 2000-2005. The data showed that Chicago, New York City, Philadelphia, 
Cleveland and Detroit were the top five cities with the highest number of children with 
EBLLs during this time period. However, LPPB acknowledges that low screening rates, 
a solid lead program and other factors confound these data. LPPB will publicize the 
data because HUD, EPA and other agencies include the information in grants language. 
LPPB will also inform grantees and other partners that reporting these data may have a 
positive or negative impact on lead programs. 
Five, LPPB will launch the "Getting the Job Done" project to provide guidance on 
eliminating EBLLs in children by 2010. The initiative is designed with five major focus 
areas. 
• 	 Intensive efforts to identify and provide services to affected children 
should be continued, such as screening and case management. 
• 	 Primary prevention efforts should be targeted to the top ten communities 
with the highest risk. LPPB and state and local health departments should 
collaborate in institutionalizing relationships between health and housing 
departments; fostering data exchange between local health and housing 
agencies; and ensuring that HUD resources are targeted to areas with the 
highest potential of poisoning children. 
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• 	 Special emphasis should be placed on unserved areas based on housing 
and socioeconomic indicators of risk. The 2010 objective cannot be 
achieved without increased efforts in Arkansas and Mississippi. 
• 	 Special programs should be developed for refugees, immigrants and other 
special risk populations to control or eliminate exposures to both paint and 
non-paint sources of lead in these groups. 
• 	 Protective surveillance systems should be developed and maintained to 
continuously monitor potential exposures to lead among U.S. children. 
Cost-effective methods should be created to sustain a low level of risk to 
exposure after elimination is achieved. LPPB hopes to release a proposal 
in early 2007 for academic institutions to identify appropriate lead 
surveillance systems. 
Six, LPPB received 43 lead poisoning prevention applications and was particularly 
pleased that Mississippi submitted a proposal. CDC funded 42 state and large-city lead 
poisoning prevention programs in FY'05, but cut LPPB's budget by $890,000 in FY'06. 
LPPB will evaluate the applications based on the following criteria: 
• 	 Implementation of screening and case management and lead elimination 
plans that target resources to children at highest risk. 
• 	 Enforcement or development of regulations that require elimination or 
control of lead hazards in housing units occupied by children with EBLLs, 
including protection to residents and tenants from retaliatory eviction or 
other lead-related discrimination. 
• 	 A current or proposed Medicaid reimbursement methodology for case 
management services and environmental inspections for Medicaid-eligible 
children. 
• 	 Electronic data collection of unit-specific housing inspection data and a 
systematic assessment of lead-safe housing status. 
• 	 Environmental screening for lead hazards in other high-risk housing. 
• 	 Strategic partnerships with child health agencies and organizations at 
federal, state, local, community and private levels. 
• 	 Cooperative state research education and extension services. 
• 	 Partnerships with HUD and EPA regional offices in targeting enforcement 
of the disclosure rule in local jurisdictions. 
LPPB will review each application three times in addition to a technical review on March 
29-30, 2006. Decisions will be made in April 2006 and the FY'07 grantees will be 
notified on June 28-29, 2006. Funds will be allocated beginning on July 1, 2006 with 
individual awards ranging from $50,000-$1 million. 
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LPPB will also establish contracts in some areas of the country with specific time-lines 
and deliverables to strengthen and ensure success of CDC's lead grant program. LPPB 
will soon award the "capacity to build capacity" contract in which non-federal staff with 
experience in lead poisoning prevention will be hired and placed in lead programs for 
-2-3 weeks. These personnel will assist programs in resolving problems related to 
Medicaid, electronic data collection and other issues. 
Seven, LPPB is continuing to provide expertise and support to UNICEF and the World 
Health Organization (WHO) in response to extremely high BLLs and the deaths of two 
children due to lead poisoning in Kosovo. Efforts are being made to transfer refugees to 
a camp. LPPB hopes that a stakeholder meeting will be convened with industry over 
the next year to explore safer strategies to remove lead from the ground in Kosovo. 
Several ACCLPP members made suggestions for LPPB to consider in its ongoing 
activities related to the deaths associated with hypocalcemia from chelation therapy. 
• 	 Inform all state medical boards about the misuse of disodium EDTA during 
chelation therapy because no state medical board has an advisory group 
that reviews each physician who performs chelation therapy. Engage Dr. 
Snodgrass to discuss the possibility of sending a letter to state medical 
boards and explore other potential strategies. However, acknowledge that 
state medical boards have no legal basis to address this issue. 
• 	 Inform AAP, the American Academy of Nurse Practitioners, and the 
American Academy of Family Practitioners about the misuse of disodium 
EDTA during chelation therapy. Use ACCLPP's liaisons to communicate 
messages and widely distribute information from CDC to the respective 
memberships of these professional associations. 
• 	 Rapidly publish a highlight in Pediatrics Experience and Reason. Use this 
quick mechanism in response to AAP's October 2005 statement that 
discusses chelation with EDT A without specifying the recommended form 
ofEDTA. 
• 	 Ensure that clear and accurate messages are delivered because previous 
news articles reported "patient deaths caused by chelation therapy" rather 
than the "use of incorrect drugs." 
• 	 Publish an addendum in AAP's weekly news magazine to clarify the title of 
the MMWR article: "Deaths Associated with Hypocalcemia from Chelation 
Therapy." Delete "chelation" because the use of this word in the title has 
contributed to the confusion and misunderstanding about the actual cause 
of death. 
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Update on Medicaid Screening 
Dr. Brown reported that she represented CDC during a recent meeting with HHS and 
CMS. CMS committed to changing its Medicaid manual if CDC revises its Medicaid 
screening guidance. CDC will take the following actions to meet CMS's conditions. A 
former ACCLPP member will be contracted to revise CDC's guidance in collaboration 
with LPPB staff. The modified guidance will outline a specific process for each state to 
review its housing, poverty and other types of data; demonstrate the absence of a lead 
problem; and make a solid case to discontinue universal screening. The specific 
elements of a targeted screening plan will be clearly defined. CDC will publish its 
revised guidance on Medicaid screening in the MMWR. 
Previous recommendations and articles on Medicaid screening developed by ACCLPP 
and CDC will be used as the foundation to update the guidance. CDC rather than CMS 
will serve as the reviewer of targeted screening plans submitted by states. CDC will 
attempt to use cost savings from universal to targeted screening to fund its new role as 
the reviewer of targeted screening plans. 
The National Committee for Quality Assurance permitted CDC to field test a health plan 
employer data and information set (HEDIS) measure for screening of Medicaid children 
at least once by two years of age. CDC will soon initiate the field test and expects to 
obtain results six to eight months after the completion of the project. CDC will attempt 
to place the revised guidance and HEDIS measure of Medicaid screening on parallel 
tracks to reasonably target resources. 
During the meeting, Dr. Brown received verbal commitments from HHS and CMS to 
pursue this course of action, but a letter was also drafted confirming that CMS will adopt 
CDC's revised guidance. The letter will be finalized and signed by the CMS Director 
within the next month. 
Dr. Brown will contact eMS to determine its willingness to adopt and implement CDC's 
revised guidance as formal policy after the final approval and clearance process is 
complete, but prior to publication in the MMWR. Both the CMS commitment letter and 
CDC's revised guidance on Medicaid screening will be distributed to ACCLPP for 
review. However, Dr. Brown clarified that CDC will not solicit ACCLPP's comments and 
formal consensus because ACCLPP's previous recommendations on Medicaid 
screening will serve as the basis to revise the guidance. 
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ACCLPP was extremely pleased about the progress that has been made over the last 
six months in Medicaid screening. The members commended Dr. Brown on her diligent 
efforts and long-standing communications with other federal agencies to advance this 
issue. 
Propoaa. to Reetructure CDC's Federal Advisory Commltt... 
Dr. Brown reported that CDC held a meeting on February 13, 2006 with the chairs and 
designated federal officials of its federal advisory committees. A new organizational 
structure was proposed to align advisory committees with CDC's 21 goals for healthy 
people, healthy places, preparedness and global health. Key changes proposed for the 
existing structure are highlighted below. 
Boards of scientific counselors (BSC) will be formed to provide advice at the center level 
on research agendas, programs, peer reviews and technical issues. Advisory 
committees will be formed to provide guidance at the coordinating center level on 
strategies and priorities, collaborations and partnerships, resources, health impact, the 
balance between research and science, and the collection, analysis and dissemination 
of information. Additional subcommittees will be formed under the Advisory Committee 
to the CDC Director. A new study section will be established to conduct initial merit 
reviews of applications throughout CDC. 
No decisions have been made on the proposed reorganization at this time, but efforts 
will be made to quickly establish a BSC for each center and an advisory committee for 
each coordinating center. Decisions will then be made on the disposition of existing 
committees. Mandated committees can only be dissolved by an act of Congress, but 
discretionary committees are retained at the discretion of the CDC Director. The three 
options proposed for the disposition of CDC's discretionary committees are disbanding, 
retaining or restructuring the groups as coordinating center subcommittees. ACCLPP is 
one of CDC's discretionary committees. 
Several members and liaisons suggested actions ACCLPP should take in responding to 
the proposed restructure of CDC's advisory committees. 
• 	 Communicate three key principles to emphasize the need to retain 
ACCLPP. First, the dissolution of ACCLPP is premature at this point. The 
current momentum to achieve the Healthy People 2010 goal for the 
elimination of childhood lead poisoning must be continued. Second, 
ACCLPP is extremely interested in integrating its focus on childhood lead 
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poisoning with the efforts of other committees that address other hazards 
in homes. Third, cost-effective methods can be identified to maintain 
ACCLPP. 
• 	 Conduct a critical review to support the retention of ACCLPP as an 
advisory committee. For example, identify specific gaps that may arise 
without ACCLPP's input, expertise and leadership as the federal 
government's only external advisory committee on childhood lead 
poisoning prevention. Highlight activities that ACCLPP conducted in direct 
response to requests by CDC and the HHS Secretary. Describe 
ACCLPP's future plans to achieve the Healthy People 2010 goal for the 
elimination of childhood lead poisoning. Compile and distribute the results 
of the critical review to the Directors of CDC and the National Center for 
Environmental Health/Agency for Toxic Substances and Disease Registry 
(NCEH/ATSDR). 
• 	 Ask the ACCLPP Chair to send a letter to the Directors of NCEH/ATSDR 
and the Coordinating Center for Environmental Health and Injury 
Prevention (CCEHIP). Use the letter to highlight ACCLPP's products, 
achievements, publications, guidance and role as a national forum for 
childhood lead poisoning prevention since 1989. 
Dr. Campbell summarized ACCLPP's next steps based on the discussion and general 
agreement among the members. Dr. Campbell, Ms. Kite and Ms. Malone will serve on 
a writing group to draft a letter outlining ACCLPP's future as a CDC advisory committee. 
Formal recommendations and other documents ACCLPP has produced since 1989 will 
be distributed to the writing group to assist in developing the draft. The letter will be 
circulated to ACCLPP for review and comment and will contain places for each voting 
member to sign. The final letter will be distributed to the CDC, CCEHIP and NCEH/ 
ATSDR Directors with a copy to Dr. Brown. 
U.,-.on the Lead and Pregnancy WorkGroup (LPWG) 
Dr. Jessica Leighton, the LPWG Chair, covered the following areas in her report. Since 
the previous ACCLPP meeting, LPWG has focused on developing an outline for the 
lead and pregnancy report. The report will be organized into the following ten chapters. 
Chapter 1 will serve as the introduction. An overview will be provided on the health 
effects of lead poisoning. The need to guide clinical decisions, inform public health 
policy, and address state legislation on pregnancy and lead po.soning will be highlighted 
as the rationale for the report. 
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Chapter 2 will serve as the background section with a review of the following areas: the 
physiology and kinetics of lead and pregnancy and lactation; recent data on the effects 
of low-level lead exposure; LPPB's experience with immigrant pregnant women and 
cases of lead exposure; and measurement issues. Chapter 3 will address 
environmental and biological measures of lead, including bone, blood, dust, air, soil, 
plasma, hair, placenta, meconium and the reliability of a single measurement. 
Chapter 4 will address the epidemiology of lead in women of child-bearing age in the 
United States. The distribution of BLLs, trends and high-risk populations will be 
discussed. Chapter 5 will address exogenous and endogenous sources of lead 
exposure in pregnant women, including leaded gas, occupational exposures, lead paint, 
personal products, cultural uses, ceramics, and past maternal exposure. Chapter 6 will 
address biochemical, sub-clinical and clinical health effects of lead to the mother, fetus 
and infant. 
Chapter 7 will contain recommendations on screening for exposure, such as appropriate 
groups, time during pregnancy, methodology and level of concern for screening. 
Specific guidance will be given on whether universal or targeted screening to high-risk 
groups is best and if a BLL measurement or questionnaire is the optimal strategy. 
Chapter 8 will address management of lead poisoning in pregnant women, including 
prevention and intervention, the role of occupational health, and follow-up testing of 
mothers and infants. Guidance will be provided on eliminating lead sources, reducing 
lead absorption through nutrition, and using chelation to decrease retention and 
increase excretion of lead. 
Chapter 9 will provide recommendations on breast-feeding and lactation issues, 
including the benefits of breast-feeding versus the risk of an EBLL and the possibility of 
lead in infant formula. Chapter 10 will address research and policy gaps and provide 
recommendations on future research and policy. 
Dr. Leighton announced that LPWG will hold two meetings in May and July 2006 to 
develop the first draft of the report, identify gaps, review recommendations, and 
determine future research and policy. From July-December 2006, LPWG will circulate 
drafts to ACCLPP for review and comment and revise each iteration of the report based 
on comments received. LPWG will submit the lead and pregnancy report to CDC in 
December 2006 to initiate the clearance process. 
ACCLPP made several suggestions for LPWG to consider in developing the first draft of 
the lead and pregnancy report. 
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• 	 Distribute each completed chapter separately to ACClPP for review and 
comment rather than the entire report at one time. 
• 	 Develop an executive summary with ten key points from the report, such 
as "prevention begins long before pregnancy." 
• 	 Chapter 1: Describe the methodology in developing the report. Explain 
that some recommendations are based on existing evidence, while others 
are based on expert opinion in the absence of data. 
• 	 Chapter 2: Describe pharmacokinetics and pharmacodynamics models of 
lead. 
• 	 Chapter 5: Include other sources of lead, such as water as a source for 
infant formula and Bll measurements and enhanced lead exposure of 
smokers. 
• 	 Chapter 6: Rename the title to "Adverse Health Effects." 
• 	 Chapters 8 and 10: Provide guidance on removing housing risks to 
eliminate lead sources to pregnant women and women of child-bearing 
age. 
• 	 Chapter 10: Describe research priorities, gaps and areas that will be most 
important in future lead and pregnancy studies. 
• 	 Chapter 10: Provide guidance on lead and pregnancy to federal, state 
and local agencies. 
Dr. leighton encouraged ACClPP to provide her with additional information on lead 
and pregnancy to support or expand lPWG's recommendations and other sections of 
the report. For example, Dr. Snodgrass has reviewed case reports of imported skin 
creams containing lead that the mother applies on the breast to relieve skin irritation. 
The infant then ingests the cream while breast-feeding. 
Update on CDC.. Auauat·2008 L..d Poleonine ItIdement 
Dr. Brown reported that the statement was mailed to ClPPPs and other partners and is 
now avaUable on the LPPB web site. LPPB did not conduct a mass mailing due to the 
large size of the document. CDC did not issue a press release because the statement 
was distributed immediately before Hurricane Katrina. Public health officials and clinical 
providers submitted numerous comments to CDC on the document. CDC's rationale for 
not lowering the Bll of concern below 10 1J9/dl continues to serve as a major source of 
controversy in the document. Dr. Brown welcomed ACClPP's suggestions on 
additional venues and organizations to distribute the 2005 lead poisoning statement. 
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Several ACCLPP members and liaisons expressed concerns that CDC did not inform 
AAP, the National Institutes of Health (NIH) and other key partners about the 2005 lead 
poisoning statement. The pediatric community is still largely unaware of the existence 
of the document. Drs. Campbell and Rogan asked LPPB to consider the following 
strategies to address these concerns. 
LPPB should notify key partners and constituencies during the early development phase 
when formulating new lead poisoning statements in the future. LPPB should send a 
letter to organizations on the MMWR mailing list and other professional associations 
represented by ACCLPP liaisons to announce the availability of the statement on the 
LPPB web site and the ability to request paper copies from CDC. LPPB should publish 
a similar notice in the MMWR. 
Update on the , ....I T_k Force on Other Sourc.. of Lead 
Dr. Brown reported that the federal interagency task force has not made tremendous 
progress to date because regulatory agencies are constrained by the limitations of 
existing statutes. For example, CPSC is prohibited from conducting pre-market testing 
of consumer products. U.S. Customs and Border Protection is not required to test all 
products that enter U.S. borders. A radical shift must be made in federal policy for the 
task force to take a more proactive approach in addressing other sources of lead. The 
task force may be able to take advantage of upcoming opportunities to advance this 
effort. 
Child health advocacy groups are expected to bring strong public attention to the recent 
death of a child due to lead poisoning that occurred in Minneapolis. The U.S.-Mexico 
Border Health Commission has agreed to address lead in candy and will discuss this 
issue at the next task force meeting. FDA posted draft guidance on lead and candy on 
its web site, but will issue the guidance as recommendations rather than enforcement 
actions. AAP, CDC, state health departments and several other groups submitted 
comments to FDA about the crltical need to release the gUldance as regulations. CDC 
and EPA are currently testing ayurvedic medicines for lead. During the next task force 
meeting in May 2006, EPA will provide an update on its Toxic Substances Control Act 
(TSCA) regulations and FDA will make a presentation on ayurvedic medicines. 
Ms. Jacqueline Mosby is the ACCLPP ex officio representative for EPA. She 
announced that EPA drafted an action plan to clearly define its federal role, 
methodology and resources to address other lead sources. EPA will solicit feedback 
from its federal partners to refine and finalize the draft action plan by the end of 2006. 
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The document will also be distributed to ACCLPP, representatives of non-governmental 
organizations and other stakeholders for review and comment. In the interim, however, 
EPA will continue its ongoing activities to address other sources of lead, such as 
outreach, education, regulatory actions and voluntary approaches to remove consumer 
products containing lead. 
Ms. Mosby added that some of the limitations within the interagency task force may be 
resolved if EPA's action plan ;5 expanded to define the roles of other federal agencies in 
addressing non-paint sources of lead. For example, a flowchart could be developed to 
illustrate regulatory authority for each federal agency to react to a specific problem; the 
appropriate chain of command for each agency to initiate and discontinue a response; 
and gaps among the missions, mandates and jurisdictions of each agency. The 
flowchart could playa significant role in fostering federal support because the agencies 
do not become involved after a consumer product containing lead is under CPSC's 
authority. However, EPA's TSCA regulations can prevent the manufacture and future 
use of a lead product after a CPSC ban. 
Dr. Warren Friedman is the ACCLPP ex officio representative for HUD. He announced 
that the latest edition of HUD's guidelines for the evaluation and control of lead-based 
paint hazards in housing is now undergoing departmental clearance. HUD may use the 
guidelines as an opportunity to focus on non-housing sources of lead because the 
document emphasizes that environmental investigations are broader than a lead-based 
paint risk assessment. HUD also intends to convey its support of wider investigations 
by local health departments. HUD expects to release the guidelines over the next 
several months. 
Dr. Friedman fully supported Ms. Mosby's proposal of a broader interagency action plan 
and suggested that the existing interagency Lead-Based Paint Task Force be used in 
this effort. This group could provide an additional forum for federal agencies to more 
clearly define roles, missions and responsibilities in addressing non-housing sources of 
lead. 
Several members and liaisons proposed actions that ACCLPP can take in supporting 
and advancing the activities of the federal interagency task force on other sources of 
lead. 
• 	 Form an ACCLPP workgroup on other sources of lead and charge the 
new workgroup with conducting the following activities. Collect solid data 
and review the literature to quantify the problem. Review the interagency 
action plan proposed by Ms. Mosby to identify gaps in existing mandates 
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and regulatory authorities of federal agencies. Formulate creative 
strategies for federal agencies to change current enforcement policies and 
models. Provide external support and guidance to the federal interagency 
task force. Develop evidence-based guidelines for CLPPPs to address 
other sources of lead while implementing lead poisoning elimination plans. 
Obtain diverse perspectives and expertise by engaging state and local 
health departments, members of EPA's National Pollution Prevention and 
Toxics Advisory Committee, child health advocacy groups, grassroots 
organizations and industrial hygienists. 
• 	 Urge the federal task force to review lessons learned and duplicate the 
success of the long-standing EPAlHUD collaboration in developing the 
new interagency action plan. 
• 	 Develop and issue a formal ACCLPP statement to cover three key areas: 
the magnitude of the problem, the statutory limitations of federal agencies, 
and strategies for agencies to establish a new regulatory threshold for 
consumer products containing lead. 
DIac....lon on New ACCLPP WorIcgroupe 
Dr. Brown asked ACCLPP to review and provide input on EPA's draft action plan and 
the new interagency road map for other sources of lead if the federal task force decides 
to undertake this effort. ACCLPP's comments on these documents would be more 
pragmatic, helpful and useful to LPPB than the formation of a new workgroup on other 
sources of lead. 
Dr. Brown pointed out that resources must be considered as well. Most notably, LPPB 
expended >$1 million to support the <10 Workgroup report and other activities. She 
also reminded ACCLPP of its charter to provide advice and recommendations on 
childhood lead poisoning prevention efforts. Suggestions for ACCLPP to address the 
relationship between exposures to lead and other heavy metals are beyond the purview 
of both LPPB and ACCLPP. Moreover, EPA and other agencies focus on heavy metals 
other than lead. 
Dr. Brown was absent during the morning session of the meeting when ACCLPP 
agreed to form a writing group on improving MHCs for primary prevention. She 
returned to this issue to provide her perspective. MHCs are not limited to lead and are 
beyond the purview of both LPPB and ACCLPP. HUD is the most appropriate agency 
to obtain external guidance and recommendations on MHCs. 
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Dr. Campbell and Ms. Kite clarified that the new ACCLPP writing group would be 
charged with identifying effective strategies and supporting ongoing efforts to 
incorporate language on primary prevention, lead hazard identification and LSWPs into 
MHCs. The writing group will also draft a letter to outline ACCLPP's concems about 
lead safety and other housing issues that impact children's health. The writing group 
will not formulate recommendations on MHCs. 
ACCLPP made several remarks in response to the suggestion to form a new broad-
based workgroup on other sources of lead with multiple stakeholders. Dr. Campbell 
proposed tabling this activity until EPA completes and distributes its action plan at the 
end of 2006. Dr. Leighton raised the possibility of holding a series of "subject matter" 
ACCLPP meetings in which guest speakers would make presentations on other sources 
of lead. The guest speakers would represent diverse perspectives and interests, 
including child health advocacy groups, grassroots and community-based organizations 
(CBOs), and state and local health departments. 
Drs. Binns and Keyvan-Larijani recommended forming a short-term interest group with 
only a few ACCLPP members and a simple charge. The small interest group would 
catalogue the most critical issues, gaps, needs, priorities and next steps related to other 
sources of lead and circulate the document to ACCLPP for review, comment and 
approval. Dr. Brown would then distribute the document to the federal task force for the 
agencies to use as a checklist while developing the interagency action plan. 
Dr. Charlton placed a motion on the floor for ACCLPP to form a small and short-term 
interest group to catalogue the most critical issues, gaps, needs, priorities and next 
steps related to other sources of lead. The motion was properly seconded by Dr. Kang 
Ho and unanimously approved by ACCLPP. Dr. Binns will chair the other sources of 
lead interest group; Mr. Hays and Drs. Charlton, Gitterman, Handy, Keyvan-Larijani and 
Leighton will serve as members. 
J.~-'::::::::::::::::::::::::::::::::::::::::::::::::::::::::~-'''~. 
Overview of the Lead Policy Stalamenl (""8) 
Dr. Benjamin Gitterman is the ACCLPP liaison to the American Public Health 
Association (APHA). He reported that a group of stakeholders from Washoe, Nevada 
submitted the LPS to APHA's governing council in June 2005. The LPS is entitled 
"Protecting Children from Overexposure to Lead in Candy and Protecting Children by 
Lowering the Blood Lead 'Level of Concem' Standard." APHA's goveming council 
approved the LPS in December 2005 and ~s executive committee will establish an 
action plan to either support or call on other agencies to respond to 12 
recommendations. 
Dr. Gitterman explained that the best approach for ACCLPP to express its concerns 
about the LPS or correct inaccuracies would be to send a letter to the Chair of the 
APHA Executive Board with a copy to the APHA President. APHA could use ACCLPP's 
letter to identify factual errors and then amend or archive the LPS. Dr. Gitterman 
committed to providing ACCLPP with a status report on whether APHA has recently 
released other policy statements on lead. 
ACCLPP was in favor of sending a letter to APHA about the LPS. On the one hand, 
several members suggested positive, diplomatic and constructive language to include in 
the letter because this approach may increase APHA's willingness to archive or amend 
the LPS. 
• 	 APHA is a respected and reputable professional association with a huge 
membership. 
• 	 APHA should make every effort to ensure that its policy statements are 
accurate, fully vetted and released as consensus because the guidance 
has tremendous implications for the broad public health field. 
• 	 Some areas of the LPS are solid and accurate. ACCLPP is pleased that 
APHA adopted these issues as policy and supports most of the 12 
recommendations outlined in the LPS. 
On the other hand, several members emphasized the need for ACCLPP to highlight 
specific errors in the LPS and express its concerns about APHA's overall process of 
developing and finalizing the LPS. 
• 	 APHA did not provide Dr. Gitterman, the ACCLPP liaison to APHA, with 
the draft LPS before finalizing and releasing the document to the public. 
This approach would have given Dr. Gitterman an opportunity to circulate 
the draft LPS to ACCLPP for review, comment and correction of factual 
errors. This process may have also minimized perceptions that the LPS 
offends the diligent efforts of ACCLPP, state health departments and other 
groups involved in lead and child health. 
• 	 The LPS should not jointly address lead in candy and the BLL of concern 
because these two issues are distinct and unrelated. 
• 	 Lines 7-11: The text does not capture the tremendous outreach efforts by 
local CLPPPs in California to inform the public and media about lead in 
imported candies, candy wrappers and seasonings. 
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• Lines 143-146: ACCLPP's 2004 draft of the <10 Workgroup report is 
referenced rather the final document that was published in August 2005. 
The draft report did not contain ACCLPP's detailed explanation about its 
position on 1 0 ~g/dL as the BLL of concern. 
• Lines 152-155: The characterization of ACCLPP's membership as "lead 
industry-connected scientists" is inaccurate. The composition of ACCLPP 
has dramatically changed since 2002 and is much more diverse in terms 
of race, ethnicity and disciplines. ACCLPP's current membership includes 
pediatricians and other clinicians, advocates for children's health and 
healthy homes, parents, lead abatement experts, academicians, and state 
and local health department officials. Advocates originally expressed 
concerns about ACCLPP's membership and should take responsibility for 
communicating with APHA about this issue. 
• Lines 238-240: ACCLPP should provide APHA with language on primary 
prevention to clarify this text. 
• Lines 242-246: The goal for laboratories to operate with a total allowable 
BLL error of ~1 ~g/dL will negatively impact the availability of lead testing. 
Many local laboratories do not have advanced equipment that is 
necessary to perform lead analyses with this level of specificity. 
Based on the discussion, Dr. Campbell summarized ACCLPP's next steps in response 
to the LPS. She will draft a letter to APHA to highlight the points ACCLPP raised during 
the meeting, but the members and liaisons should provide her with additional comments 
by April 14, 2006. The draft letter will be circulated to ACCLPP for review and input and 
revised based on any comments submitted. Dr. Campbell will also ask Drs. Gitterman 
and Stubbs-Wynn to review the letter from an APHA organizational perspective. The 
final letter will be sent to the APHA Executive Board Chair and President. 
:Publlc Com....nt .-.ted 
Dr. Friedman announced that HUD recently published notices of funding availability 
(NOFAs) for healthy homes and lead grants, including lead hazard control, lead 
technical studies and lead outreach activities. Each state or local governmental agency 
can increase its application score by demonstrating collaborations with CBOs and faith­
based organizations in conducting activities and research under HUD's lead programs. 
State and local grantees are required to integrate activities under HUD's lead programs 
with activities under CDC's lead strategic plans in local jurisdictions. The NOFAs can 
be viewed on the HUD web site. 
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With no further discussion or business brought before ACCLPP, Dr. Campbell recessed 
the meeting at 5:29 p.m. on March 21, 2006. 
ClHllna4t8 to the ACCLPP Membe,..hlp 
Dr. Campbell reconvened the ACCLPP meeting at 8:33 a.m. on March 22, 2006 and 
yielded the floor to the first presenter. Dr. Brown announced that the terms of the 
ACCLPP Chair and a member will soon expire. She acknowledged and thanked Drs. 
Campbell and Slota-Varma for their outstanding service to ACCLPP and CDC; valuable 
contributions to the health of children in the United States; and tremendous efforts to 
prevent lead pOisoning at local, state and federal levels. Dr. Brown presented the 
outgoing members with plaques and letters signed by the CDC Director. Dr. Campbell 
was presented with an additional plaque in recognition of her eight-year service as both 
the ACCLPP Chair and a member. 
Dr. Brown made additional announcements about changes in ACCLPP's membership. 
Ms. Kite's original one-year term was extended to a full term. A voting member needs 
to soon volunteer to serve as the new ACCLPP Chair. The ACCLPP Chair has 
traditionally been a pediatrician, but the charter does not outline specific requirements 
for this position. Two new members will greatly contribute to ACCLPP's deliberations. 
Dr. Deborah Cory-Slechta, of the University of Medicine and Dentistry of New Jersey, 
has expertise in psychology, bench science and the developmental effects of lead. Dr. 
Sherry Lynn Gardner is the Chief of Pediatrics at Grady Memorial Hospital in Atlanta, 
Georgia and has a wealth of clinical expertise. 
nil !i ! 'I !!I!!!!!!!!!!!!!!!!!!!! 
New o.ta Oil Cet,.elllfNntlll Iftd,Neu,.,.,.II......,~ 
Dr. Walter Rogan is the ACCLPP ex officio representative for NIH. He presented data 
from a clinical trial that focused on 10 and BLLs in children 2-7 years of age to 
determine whether effects in older children are residual of high Blls in children 2 
of age. BLLs in U.S. children tend to peak at 2 years of age and then decline. A meta­
analysis of four prospective studies that was conducted in 1994 did not show a 
relationship between the mother's BLL measured around birth and 10 measured at 
school age. However, the peak BLL at around 2 years of age and the postnatal mean 
BLL showed an association with 10 measured at ~5 years of age. 
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Children 2 years of age should be recruited and followed until 5 years of age to analyze 
the peak lead effect and determine its impact on 10. However, lead poisoning 
screening has traditionally focused on children 1-2 years of age and clinical trials have 
historically treated children 2 years of age. Previous prospective studies conducted in 
Boston, Cincinnati and Rochester did not include a detailed analysis of the association 
between 10 and the peak BLL at 2 years of age. 
In an effort to fill this gap, data from the Treatment of Lead-exposed Children (TLC) 
study were used to identify the strength of the association between BLLs and 10 at 
various time points and determine whether cross-sectional associations observed in 
school-age children represent residual effects from peak BLLs. The TLC trial served as 
a solid data source for the new study due to its large sample size, rigorous degree of 
testing, quality control measures, longitudinal design and high retention rate. However, 
no home observations for measurement of the environment (HOME) score were 
conducted for the TLC cohort. 
TLC was a randomized placebo-controlled clinical trial of succi mer with the primary 
outcome focusing on 10 measured at 5 and 7 years of age. The cohort included 780 
children 12-33 months of age with BLLs ranging from 20-44 ~g/dL. Of the entire cohort, 
396 children were in the succimer group, 384 were in the placebo group, 77% were 
African American, 56% were male, 95% were English speaking, 40% had parents with 
less than a high school education, 72% had single parents, and 97% were on public 
assistance. The cohort was followed up to 60 months after treatment until 7 years of 
age. 
TLC was conducted at multiple centers in Baltimore, CinCinnati, Newark and 
Philadelphia. BLLs were measured at baseline, frequent intervals over the course of 
treatment and follow-up. 10 was measured with standardized instruments at 2,5 and 7 
years of age. The 10 of the mother or other care giver was measured as well. A 
statistical analysis was performed with TLC data using general linear models, 
untransformed BLLs and important covariates. The succimer and placebo groups were 
combined because no treatment effect on 10 was observed. 
In the new longitudinal study, BLLs were measured at baseline, at 2 years of age, at the 
36-month follow-up at 5 years age, and at the 60-month follow-up at 7 years of age. 
The mental development index and 10 were measured to determine relationships 
among the three different age periods. Results of the model are outlined below. 
A -3-point 10 deficit was observed for every 1 0 ~g/dL change in BLL at 2 years of age. 
A 2-point 10 deficit was observed at 5 years of age for every 1 0 ~g/dL change in BLL at 
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2 years of age. A 1-point 10 deficit was observed at 7 years of age for every 10 1J9/dl 
change in Bll at 2 years of age, but this result was not statistically significant. A 5­
point 10 deficit was observed at 7 years of age cross-sectionally for every 10 IJg/dl 
change in Bll at 2 years of age. 
A larger response was seen in older children than younger children per unit change in 
Blls. The concurrent Bll and 10 at 5 years of age were larger than the Bll and 10 at 
2 years of age. This result was statistically significant. Blls at 5 years of age showed 
a larger effect on 10 at 7 years of age than Blls at 2 years of age. 
Children with Blls below the median at both 2 and 7 years of age had an 10 of 89. A 
3.6-point 10 deficit was seen in children with Blls below the median at 2 years of age 
and above the median at 7 years of age. No effect on 10 was seen in children with 
Blls above the median at 2 years of age and below the median at 7 years of age. No 
additive effects on 10 were seen in children with Blls above the median at both 2 and 7 
years of age. Similar results were seen with 10 at 5 years of age. 
The following conclusions were reached based on the findings of the new longitudinal 
study. A stronger association was observed between Blls and 10 at 7 years of age 
than between the higher Bll at 2 years of age and 10 at 7 years of age. The strength 
of the cross-sectional association increased over time. The results support the theory 
that lead exposure continues to be toxic to children as they reach school age, but not all 
of the damage occurred by the time the child was 2-3 years of age. lead exposure 
near school age may affect cognition. Difficulties in preventing lead exposure are 
greater, but the potential increases. 
Dr. Kim Dietrich, of the University of Cincinnati, presented data to demonstrate the 
potential importance of later Blls on periods of enhanced developmental susceptibility 
to central nervous system (CNS) effects of environmental lead. AAP's 2005 policy 
statement strongly recommended that all Medicaid-eligible children receive at least two 
screenings at 1 and 2 years of age. The policy further noted that a "low" Bll in a 
school-age child does not rule out earlier lead poisoning. 
The Boston prospective study was published in 1992 and found that Blls at 24 months 
of age were exclusively associated with neurodevelopmental deficits. The study also 
showed that 2 years of age is the critical period of exposure and when the most damage 
occurs. These findings had a tremendous impact on CDC recommending lead 
screening at 2 years of age. More recent data have been collected to support the 
results of the Boston prospective study, but stronger emphasis should now be placed on 
the implications of Blls beyond 2 years of age. 
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Blood lead is often considered to be merely a measure of recent exposure, but late 
Blls represent exposures from both exogenous and endogenous sources. Blood lead 
reflects an equilibrium between body burden and ongoing exposure to environmental 
sources at any given point in time, such as a young school-age child. Blood lead 
measured concurrently with measures of neurodevelopmental outcomes may be better 
predictors of deficit. Blood lead measured concurrently with an assessment of outcome 
may be a better indicator of biologic levels of exposure to the CNS or other target organ. 
Higher Blls in later life may represent individual differences in absorption, retention 
and vulnerability. 
A study was published in 1995 comparing findings from the Boston prospective study 
and more recent data. The impact of certain sensitive periods on neurocognitive 
development was analyzed in the study. Covariate adjusted regression coefficients for 
Blls on performance 10 by year of serial Blls assessment were measured. The 
analysis showed that the regression coefficients became statistically significant after 3 
years of age in terms of predicting deficits in performance 10. The results suggested 
that late measures of lead exposure are important and may be better indicators of the 
effects of toxicants on target organs. The most significant relationship between Bll 
and 10 was observed at 6 years of age rather than assessments at 1 or 2 years of age. 
Evidence from five studies conducted from 1996-2005 did not clearly demonstrate that 
only the period of peak Blls at 2 years of age is important in terms of risks for 
neurodevelopmental vulnerability. These five studies showed similar results as the 
1995 study in which later Blls were found to be more predictive of neurodevelopmental 
deficits in children beyond 2 years of age. Data from the National Health And Nutrition 
Examination Survey (NHANES) on >1,400 children 6-16 years of age were analyzed in 
2000 and showed a highly significant relationship between reading scores and 
concurrent Blls <10 ~g/dL. 
An international pooled analysis of data from seven prospective studies was conducted 
in 2005 focusing on low-level environmental lead exposure and children's intellectual 
function. The analysis was designed with three major objectives. The relationship 
between 10 and Blls in children followed prospectively from infancy through 5-10 years 
of age was examined. Evidence of lead-associated decrements in 10 scores at Blls 
< 1 0 ~g/dL was tested. A determination was made on whether lead-associated 10 deficit 
was greater for a given change in exposure for children with lower peak Blls. 
Four different Bll measures were defined for the analysis. The "peak Bll" was the 
maximum Bll of blood lead tests taken at 6 months, 1 year or 15 months, and 2-7 
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years of age. The "early childhood Bll" was the mean Bll from 6-24 months of age. 
The "mean lifetime average" was the mean Bll from 6 months of age to the concurrent 
value. The "concurrent Bll" was the blood lead value at the age concurrent with 10 
testing or otherwise closest to 10 testing for each site. The data were adjusted for the 
following covariates: the child's gender, birth order and birth weight; HOME score; and 
maternal 10, education, age at delivery, marital status, prenatal smoking and alcohol 
use. 
An adjusted log-linear model and a restricted cubic spline function were used to 
examine the following areas: (1) the relationship between 10 and selected blood lead 
indices adjusted for all available covariates; (2) the relationship between full-scale 10 
and selected blood lead indices; (3) the relationship between concurrent Blls and 
children's intellectual function; (4) estimated lead-associated 10 deficits by concurrent 
Blls; and (5) the relationship between concurrent Blls and children's intellectual 
function at Blls above and below 10 ~g/dL. 
The log Bll, HOME score, birth weight, and maternal 10 and education showed the 
most significant associations to 10. Estimates of a 9.2-point 10 deficit with concurrent 
Blls ranging from <1-30 ~g/dl and a 6.2-point 10 deficit with concurrent Blls ranging 
from <1-10 ~g/dl were found to be clinically strong. The key findings and conclusions 
of the international pooled analysis are highlighted below. 
The data support the hypothesis that lead-associated intellectual deficits occur at Blls 
<10 ~g/dL. This threshold is the current action level established by CDC and WHO. 
The decrease in 10 per unit Bll was greatest at Blls <10 ~g/dL. No evidence was 
seen of a threshold of lead-associated intellectual deficits. The data strongly suggest 
the need for continued risk assessment beyond 2 years of age. The pooled analysis 
and other data provide sufficient evidence to launch an aggressive campaign to 
eliminate childhood lead exposure. Overall, findings from pediatric lead studies do not 
indicate any particularly critical period of vulnerability. The current focus on screening 
for EBlls in children only through 2 years of age may be insufficient. 
Dr. Brown was pleased that the data presented by Drs. Dietrich and Rogan strengthen 
the current national focus on primary prevention by ACClPP, CDC, state and local 
ClPPPs, and professional organizations. However, she was concerned about the 
potential for the data to be used to support widespread screening of school-age 
children. The most recent NHANES data show that the geometric mean Bll of school­
age children is -0.9 ~g/dL. 
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Dr. Campbell pointed out that the data raise the issue of the extent to which aggressive 
efforts should be made to lower EBLLs at 2 years of age to eliminate continued damage 
to cognition. Dr. Slota-Varma recommended publishing the data in Pediatrics and other 
venues that are targeted to providers and public health officials. Dr. Rogan clarified that 
the data are too technical and dependent on models for publication in journals targeted 
to providers. Dr. Binns reminded ACCLPP that the clinical paper will soon be published 
in Pediatrics and the MMWR and contains a paragraph on the data. 
Overview of the coneln State Lead IlImlnatton Plan (LEP) 
Dr. Catherine Slota-Varma is an ACCLPP member and an Associate Clinical Professor 
in the Department of Pediatrjcs at the Medical College of Wisconsin. She described 
current efforts to eliminate lead poisoning in Wisconsin by 2010. The state formed a 
planning group for the LEP in 2003 and engaged a broad range of stakeholders 
representing rental property owners, healthcare, housing agencies, state and local 
governments, businesses, public health and child advocacy organizations. The 
planning sessions resulted in the identification of four categories of concern for the LEP: 
providing education, correcting lead hazards in housing, allocating funding and 
resources, and targeting high-risk populations. 
The LEP was developed with strategies, objectives, performance measures and time­
lines for each category of concern. Four subcommittees were formed to focus on each 
category. An Implementation and Oversight Committee was established to monitor the 
activities of the subcommittees. CDC responded favorably to the Wisconsin LEP, 
particularly its comprehensiveness and emphasis on the depth of the childhood lead 
poisoning problem in the state. The LEP, state statutes, lead-free and lead-safe 
housing registry, and other lead poisoning resources throughout the state can be 
accessed on dhfs.wisconsin.gov. 
The LEP extensively defines the scope of the childhood lead pOisoning problem in 
Wisconsin. In 2004, - 3,300 children were lead poisoned. The lead poisoning rate in 
Wisconsin of 3.9% is more than twice the national average of 1.6%. Milwaukee has an 
overall lead poisoning rate of 9.2%, but two zip codes in the city have rates of -25% 
each. Data collected from Milwaukee showed that the screening rate of children 1-2 
years of age only increased from 46.9% in 1999 to 53% in 2004. High-risk populations 
in the state are characterized by <6 years of age and residence in a home older than 
1950 or 1978 with renovation. Of Wisconsin's high-risk population, 82% are on 
Medicaid. 
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Of Wisconsin's 600,000-660,000 dwellings, 120,000 are occupied by children <6 years 
of age. The state uses geographic information systems to pinpoint zip codes, streets 
and individual addresses of high-risk dwellings. Based on a cost analysis of cleanup for 
120,000 homes, $240 million would be needed for window abatement at $2,000 per 
home and $1.32 billion would be needed for full abatement at $11,000 per home. 
Wisconsin receives $6-$7 million annually from federal and private sources to address 
childhood lead poisoning, but another cost analysis showed that the state can save 
-$14 million by eliminating lead poisoning. The savings would be based on costs for 
special education, medical care, juvenile justice and loss of future income. 
Despite the magnitude of its childhood lead poisoning problem, Wisconsin has achieved 
success with the LEP. Milwaukee established a national reputation in primary 
prevention, developed a citywide LEP, obtained several HUD grants, and integrated the 
local health department and public housing agencies to strengthen enforcement 
activities. Milwaukee now only needs 30-40 days to repair old homes after receiving a 
report compared to -260 days in other areas of the state. Other local successes 
include an expansion of home visitation programs with health department nurses, a 
dramatic decrease in lead levels with an exterior inspection model, and improved 
enforcement capacity. 
Wisconsin implemented a new rule in 2005 reqUiring inspectors to check for 
deteriorated or flaking paint in potentially new day care centers. Educational efforts are 
now directed to day care providers because the state disapproved several applications 
for new day care centers based on the 2005 inspection rule. The day care "child health 
report" form was revised to include mandates for testing of Medicaid-eligible children 
and a new question requiring physicians to provide the date of the child's last blood test. 
A lead test will be incorporated into Wisconsin's electronic immunization registry. The 
state Medicaid program has made a commitment to fully fund the cost of software that 
will be required to make this change. 
Physician report cards are mailed annually to all providers in the state who screened 
>50 children for lead poisoning in the previous year. The report cards provide 
physicians with their individual testing rates based on the number of children seen, 
tested and not tested at 1-5 years of age. The report cards also contain a bar graph 
comparing the physician's adherence to Medicaid testing requirements and the best 
compliance rates of ten other providers. A cover letter accompanies the report card 
offering to provide the physician with the names of children who were seen, but not 
tested. The local health department will administer a follow-up survey to the report cards 
in Milwaukee to obtain feedback from and offer lead screening assistance to physicians. 
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Wisconsin continues to receive funding from CDC, HUD and private sources to support 
the LEP and primary prevention efforts. A housing trust fund was established in 
Milwaukee to provide low-interest loans and rebates to persons who perform lead 
hazard control activities. Efforts will be made in the future to expand the housing trust 
fund throughout the state. Wisconsin's other funding sources for lead hazard control 
include fees from the transfer of real estate and a redirection of state general funds. 
The Wisconsin Senate and Assembly Committees recently passed a window 
replacement bill. Report cards with maps of addresses where children have been lead 
poisoned in each legislative district are being hand-delivered to state senators and 
representatives of these districts. National legislation was introduced to provide tax 
credits for abatement and renovation. Wisconsin hosted a "Lead Poisoning Prevention 
Week" in October 2005 with local community events, press conferences and media 
coverage. The state's educational activities and other efforts have tremendously 
increased advocacy, support and awareness of Wisconsin's childhood lead poisoning 
problem at both governmental and non-governmental levels. 
Dr. Brown invited Dr. Slota-Varma to attend a future ACCLPP meeting and provide an 
update on the physician report cards and Wisconsin's other lead elimination activities. 
She raised the possibility of LPPB compiling the lead strategic plans of all grantees to 
highlight the similarities and individual differences. While this activity is being 
considered, Dr. Brown encouraged ACCLPP to review the lead screening and strategic 
plans of all grantees on the LPPB web site. 
Ms. Margot Tracy is a master's student at the Harvard School of Public Health. She 
and another student collaborated with the Houston CLPPP to implement the "Building 
the Evaluation Framework" project. The Children's Environmental Health Bureau 
(CEHB) houses the Houston CLPPP and a lead-based paint hazard control program. 
However, CEHB provides clinical management, but does offer environmental 
services to children living in public housing identified with EBLLs. Multi-family housing 
(MFH) remediates properties, but does not have the infrastructure to identify and refer 
children with EBLLs to CEBH for clinical management. This system does not enable 
health and housing agencies to share data, collaborate and communicate in childhood 
lead poisoning elimination. 
The project was designed to bridge gaps between primary and secondary prevention by 
integrating CEHB's clinical services and MFH's remediation services. A memorandum 
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of understanding (MOU) was developed to clearly define collaborative efforts between 
CEHB and MFH and improve coordination of lead poisoning prevention activities. A 
logic model was also created with objectives, specific activities and measurable 
indicators to illustrate the sequence of events that should occur to achieve the goals of 
the project. 
For example, the objective of increased information sharing between CEHB and MFH 
would be achieved by providing the lead certification status of all MFH properties and 
exchanging data on properties that may have poisoned children. MFH's quarterly 
updated list to CEHB of all MFH properties, all properties exempt from lead certification 
and the lead status of non-exempt properties would serve as an indicator on the 
housing side. CEHB's quarterly updates to MFH on properties that were identified as 
non-certified and may have poisoned a child would serve as an indicator on the health 
side. 
Ms. Tracy thanked CDC and the Houston ClPPP for educating her on evaluation and 
providing an invaluable opportunity to apply this knowledge in actual practice. She 
hoped that the "building the evaluation framework" model could be broadened to 
strengthen relationships between health and housing departments throughout the 
country. She was extremely pleased that the implementation of the project fostered 
collaboration and coordination between CEHB and MFH. 
Dr. Brenda Reyes, the Houston ClPPP Director, described the current status of the 
"building the evaluation framework" model. The project was completed in January 
2006, but the logic model is not being formally implemented at this time. The legal, 
housing and health departments have not completed the clearance and approval 
process for the MOU. However, the Houston ClPPP is informally conducting some of 
the activities described in the logic model. Children with EBlls who reside in MFH 
properties are being identified. The draft logic model was distributed to state and local 
health departments, the broader housing community and HUD grantees. Each partner 
agency and organization has made a commitment to adopt the logic model after the 
clearance and approval process is complete. 
Dr. Reyes also summarized the extremely positive impacts of the project on Houston 
ClPPP staff. The focus on lead was strengthened and knowledge of the evaluation 
process was enhanced. Collaborative efforts were undertaken with students from the 
nation's leading public health school to develop a logic model. The "building the 
evaluation framework" model is a living document that can be changed to meet the 
different needs of the partner agencies over time. MFH's high level of support and 
interest in the project facilitated coordination and collaboration with CEHB. Positive 
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feedback about the project was expressed at all levels of the Houston ClPPP from 
leadership to program staff. 
Dr. Brown hoped EPA and HUD would develop similar programs with schools of public 
health. Each ClPPP that has participated in the program has provided CDC with 
extremely favorable, supportive and positive feedback of its experience. 
Dr. Robert Bossarte of CDC described the public health impact in the United States of 
misclassifying or using defective sensors with the leadCare blood lead testing 
instrument. Previous comparisons of results obtained with leadCare and graphite 
furnace atomic absorption spectrometry (GFAAS) supported the use of portable testing 
units for onsite screening. In May 2005, proficiency testing revealed a negative bias in 
Blls that were obtained with the leadCare portable blood lead testing device. In 
response to these results, the leadCare manufacturer launched a recall of defective 
Bll testing sensors on May 19, 2005. 
The eight lots of recalled testing sensors were distributed from September 2004-May 
2005 with expiration dates from February 2005-July 2006. The distribution and use of 
recalled sensors may have resulted in the misclassification of Blls among -500,000 
persons. CDC conducted a study to quantify the public health impact of the recall and 
answer two research questions. First, did the average Bll decrease compared to the 
average Bll before the defective sensors were placed on the market? Second, did the 
bias adversely affect any individual by not providing medical, worker or environmental 
protection in a timely manner? 
CDC requested laboratory data from 15 high-volume leadCare facilities in the United 
States and all data from January 1, 2003-June 30, 2005. These data included the test 
date, sample type, result, sensor lot number, patient's age and retest results when 
available, Of the 15 clinica! sites, 53% contributed 26.883 records. Of the 
26,883 records, 47% contained a lot number identification. All results were obtained 
using capillary samples. The eight contributing facilities represented the Northeast, 
Midwest and West geographic regions and the states of California, Massachusetts, 
Michigan, Missouri and New York. 
Data supplied by the facilities were stratified to analyze the following areas: (1) the 
availability of defective sensors and mean differences in Blls before and after the recall 
in age groups of 0-6,7-15 and >16 years; (2) mean differences in the three age groups 
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and the recall status with known lot numbers; and (3) differences in test and retest 
results with and without defective sensors. The limitations of the study include a small 
geographical area and sample of laboratories, a minimal number of retested patients, 
limited demographic information, and the sole use of capillary samples. 
The analyses of the data showed the following results. A significant negative bias 
among BLLs was seen when defective sensors were available or used. Older children 
and adults may have been more severely impacted by the recall. The misclassification 
may have affected the treatment of >50% of persons tested with defective sensors. 
Poor techniques may have resulted in a misclassification. 
CDC made three key recommendations based on these findings. Proficiency testing 
should be continued to identify defective testing systems. Persons tested between 
September 2003 and May 2005 with BLLs ~5 ~g/dL should be retested. The LeadCare 
field testing unit should not be used for confirmatory testing. 
Mr. Jeff Jarrett of CDC announced that the LeadCare II instrument for blood lead 
screening is certified for use in the field, but is not commercially available. A Clinical 
Laboratory Improvement Amendments waiver has not been approved at this time 
because the instrument is still classified as "moderately complex" and proficiency testing 
issues have not been resolved. 
The manufacturer claims that the accuracy of the LeadCare II instrument will be within 
95% of GFAAS results based on measures of 14.4% at 5.35 ~g/dL and 9.95% at 28.5 
~g/dL. The error rate of the LeadCare II instrument is expected to be <:t2. The FDA 
closed the recall on the lots of previous LeadCare testing sensors. 
.'----------...------------..... ------~' NewACCL..' .......... 

Ms. Johnson noted that federal housing dollars should be consistent with the regulatory 
language of Section 8, but this policy is not routinely followed in Rochester, New York. 
Perceptions of a reduction in Section 8 funds may be contributing to an increase in lead 
hazards to families at the local level. Ms. Johnson questioned whether other ACCLPP 
members have noticed this trend in other areas of the country. 
Ms. Odie reported that Connecticut strictly adheres to lead-safe housing rules requiring 
the identification of chipping and peeling paint in Section 8 housing. The state has seen 
an increase rather than a decrease in compliance to these regulations. Dr. Campbell 
mentioned that the city of Philadelphia engaged health and housing agencies in 2002 to 
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make drastic changes in improving inspections of Section 8 housing and enforcing 
remediation of identified lead violations. 
Dr. Handy emphasized the need to engage local health departments and other groups 
outside of HUD to address primary prevention in Section 8 housing. The amount of 
funds currently offered to property owners for reimbursement of Section 8 tenants is 
diminishing. The number of property owners who are willing to rent units to persons in 
Section 8 and other federally-subsidized housing programs is also decreasing. 
Organizations and agencies outside of HUD can provide information on the number of 
dwellings cited for housing children with EBlls and property owners who receive no 
federal assistance. 
Ms. Malone announced that AFHH has initiated dialogues with Fannie Mae, Freddie 
Mac and other government-sponsored enterprises to incorporate language on housing 
conditions into mortgage materials developed by these groups. She strongly 
encouraged ACClPP to become involved in this initiative. 
Drs. Brown and Friedman made a commitment to determine whether the federal 
interagency Lead-Based Paint Task Force is willing to address primary prevention in 
Section 8 housing. In the interim, however, Dr. Brown challenged ACClPP with broadly 
defining "federally-assisted housing." She clarified that federal agencies other than 
HUD and quasi-governmental agencies also own or provide funding for federally­
assisted properties. Dr. Brown confirmed that ACClPP will revisit primary prevention in 
Section 8 housing at a future meeting. Dr. Friedman's update on HUD's Title X housing 
assistance regulations will be included in this agenda item . 
................----.....................~ ....------~--------~ 

Ms. Judy Zoch, of the Harris County, Texas Department of Environmental Public Health, 
reported that the agency sees more cases of EBlls in children than many urban health 
departments. Of 20 children with EBlls ranging from 20-48 ~g/dL reported to Harris 
County over the last two years, 18 were Hispanic and two were African American. Of 
these cases, 12 were caused by non-paint sources and six were caused by lead paint. 
At least three of the mothers of the children had pica during pregnancy and persistent 
EBlls. 
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The next ACCLPP meeting will be held on October 17-18. 2006 in Atlanta, Georgia. Dr. 
Campbell acknowledged the diligent efforts of Ms. Claudine Johnson in organizing and 
making the logistical arrangements for the meeting. 
With no further discussion or business brought before ACCLPP. Dr. Campbell 
adjourned the meeting at 12:34 p.m. on March 22. 2006. 
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